-
Je něco špatně v tomto záznamu ?
ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 2 - reagent selection and assay optimization for high-sensitivity testing
DR. Sutherland, A. Illingworth, I. Marinov, F. Ortiz, J. Andreasen, D. Payne, PK. Wallace, M. Keeney,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 2002
Medline Complete (EBSCOhost)
od 2012-03-01 do Před 1 rokem
Wiley Free Content
od 2003
PubMed
29236353
DOI
10.1002/cyto.b.21610
Knihovny.cz E-zdroje
- MeSH
- erytrocyty metabolismus MeSH
- konsensus MeSH
- leukocyty metabolismus MeSH
- lidé MeSH
- monocyty metabolismus MeSH
- neutrofily metabolismus MeSH
- paroxysmální hemoglobinurie diagnóza metabolismus MeSH
- počet leukocytů metody MeSH
- průtoková cytometrie normy MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Since publication in 2010 of the International Clinical Cytometry Society (ICCS) Consensus Guidelines for detection of Paroxysmal nocturnal hemoglobinuria (PNH) by flow cytometery, a great deal of work has been performed to develop, optimize, and validate a number of high-sensitivity assays to detect PNH phenotypes in both red blood cells (RBCs) and white blood cells (WBCs, neutrophils, and monocytes). This section (Part 2) of the updated ICCS PNH Consensus Guidelines will focus on specific instrument setup for these PNH assays, the identification and proper testing of appropriate antibody conjugates and combinations therof, and basic assay design. © 2017 International Clinical Cytometry Society.
Dahl Chase Diagnostic Services in Bangor Bangor Maine
Department of Flow and Image Cytometry Roswell Park Cancer Institute Buffalo New York
Department of Hematology Flow Cytometry London Health Sciences Centre London Ontario Canada
Immunologic Flow Cytometry ARUP Laboratories Inc Salt Lake City Utah
Institute of Hematology and Blood Transfusion Prague Czech Republic
University Health Network Toronto General Hospital Ontario M5G2C4 Canada
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19028666
- 003
- CZ-PrNML
- 005
- 20190819122249.0
- 007
- ta
- 008
- 190813s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1002/cyto.b.21610 $2 doi
- 035 __
- $a (PubMed)29236353
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Sutherland, D Robert $u University Health Network, Toronto General Hospital, Ontario M5G2C4, Canada.
- 245 10
- $a ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 2 - reagent selection and assay optimization for high-sensitivity testing / $c DR. Sutherland, A. Illingworth, I. Marinov, F. Ortiz, J. Andreasen, D. Payne, PK. Wallace, M. Keeney,
- 520 9_
- $a Since publication in 2010 of the International Clinical Cytometry Society (ICCS) Consensus Guidelines for detection of Paroxysmal nocturnal hemoglobinuria (PNH) by flow cytometery, a great deal of work has been performed to develop, optimize, and validate a number of high-sensitivity assays to detect PNH phenotypes in both red blood cells (RBCs) and white blood cells (WBCs, neutrophils, and monocytes). This section (Part 2) of the updated ICCS PNH Consensus Guidelines will focus on specific instrument setup for these PNH assays, the identification and proper testing of appropriate antibody conjugates and combinations therof, and basic assay design. © 2017 International Clinical Cytometry Society.
- 650 _2
- $a konsensus $7 D032921
- 650 _2
- $a erytrocyty $x metabolismus $7 D004912
- 650 _2
- $a průtoková cytometrie $x normy $7 D005434
- 650 _2
- $a paroxysmální hemoglobinurie $x diagnóza $x metabolismus $7 D006457
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a počet leukocytů $x metody $7 D007958
- 650 _2
- $a leukocyty $x metabolismus $7 D007962
- 650 _2
- $a monocyty $x metabolismus $7 D009000
- 650 _2
- $a neutrofily $x metabolismus $7 D009504
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Illingworth, Andrea $u Dahl-Chase Diagnostic Services in Bangor, Bangor, Maine.
- 700 1_
- $a Marinov, Iuri $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
- 700 1_
- $a Ortiz, Fernando $u University Health Network, Toronto General Hospital, Ontario M5G2C4, Canada.
- 700 1_
- $a Andreasen, John $u Immunologic Flow Cytometry, ARUP Laboratories, Inc, Salt Lake City, Utah.
- 700 1_
- $a Payne, Dan $u HMDL and Immunology Flow Cytometry Service, Leicester Royal Infirmary UHL NHS Trust, Leicester, United Kingdom.
- 700 1_
- $a Wallace, Paul K $u Department of Flow and Image Cytometry, Roswell Park Cancer Institute, Buffalo, New York.
- 700 1_
- $a Keeney, Michael $u Department of Hematology/Flow Cytometry London Health Sciences Centre, London, Ontario, Canada.
- 773 0_
- $w MED00013936 $t Cytometry. Part B, Clinical cytometry $x 1552-4957 $g Roč. 94, č. 1 (2018), s. 23-48
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29236353 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190813 $b ABA008
- 991 __
- $a 20190819122523 $b ABA008
- 999 __
- $a ok $b bmc $g 1433815 $s 1067126
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 94 $c 1 $d 23-48 $e - $i 1552-4957 $m Cytometry. Part B, Clinical cytometry $n Cytometry B Clin Cytom $x MED00013936
- LZP __
- $a Pubmed-20190813